Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 30 September 2026.

Announcements

2,182

Total raised

£9.5B

disclosed amounts

This month

£22.4M

raised so far

Seed
£1.3M

The investment was backed by the GMC Life Sciences Fund By Praetura and NPIF II, Praetura Equity Finance.

"We’re building a future where everyone has the tools and confidence to take control of their health — wherever they are. This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care. Prevention has to be proactive, accessible and data-informed — and that’s exactly what SiSU Health delivers."
— Samantha Fay, CEO
Seed
$5.5M

The seed round drew backing from professionals across prominent financial and legal institutions.

"Private equity is full of brilliant people working with ancient tools. We built Dealstack because highly qualified professionals shouldn’t be stuck copying and pasting data from spreadsheets to PDFs when AI and automated workflows can do that for them."
— Seb Lapinski, COO
Seed
£750K

The biotechnology firm raised fresh capital to accelerate growth in American and European markets and complete new laboratory facilities.

"Over the last year we’ve demonstrated the market for novel and improved in vitro testing methods and expanded our customer base as well as the Aelius team. Along with our move to our new premises, this latest funding will enable us to accelerate our growth in international markets, particularly in the US."
— Peter Chater, CEO
Seed
£780K

Equity Gap led the seed financing for the Edinburgh based manufacturer of custom fit respirators, with backing from Scottish Enterprise, Old College Capital, and Apollo Informal Investment.

"We realised that by combining modern 3D imaging with 3D-printed soft materials, we could create bespoke, perfectly fitted masks that conform to the unique contours of each face. In our first comparative trial, our masks proved more comfortable than standard disposable alternatives. Since then, we’ve refined our design dramatically yet we’ve remained true to our original mission: to create the most comfortable, personalised respiratory masks possible, suited for every face. We believe the days of painful, pressure-inducing masks are finally over."
— Ken Stewart, NHS consultant surgeon